Showing results (11-20 of 359) with videos related to
Sort By:
Pageof 36
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2021
Comparison of pretherapeutic osseous tumor volume and standard hematology for prediction of hematotoxicity after PSMA-targeted radioligand therapyLiam Widjaja, Rudolf A Werner, Tobias L Ross, et al.Cancers|July 2, 2021
PSMA Expression Predicts Early Biochemical Response in Patients with Metastatic Castration-Resistant Prostate Cancer under <sup>177</sup>Lu-PSMA-617 Radioligand TherapyLiam Widjaja, Rudolf A Werner, Tobias L Ross, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 15, 2020
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumorsFiona Ohlendorf, Christoph Henkenberens, Thomas Brunkhorst, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2015
A randomized, double-blind, crossover comparison of novel continuous bed motion versus traditional bed position whole-body PET/CT imagingImke Schatka, Desiree Weiberg, Stephanie Reichelt, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2022
Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapyLiam Widjaja, Rudolf A Werner, Elke Krischke, et al.Diagnostics (Basel, Switzerland)|April 3, 2021
Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide TherapyFiona Ohlendorf, Rudolf A Werner, Christoph Henkenberens, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2025
<sup>99m</sup>Tc-MIP-1404 SPECT/CT Companion Diagnostic for <sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate CancerThorsten Derlin, Liam Widjaja, Nina Natascha Harke, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2015
Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT studyThorsten Derlin, Haefaa Alchalby, Peter Bannas, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
<sup>18</sup>F-FDG PET/CT in Left-Ventricular Assist Device Infection: Initial Results Supporting the Usefulness of Image-Guided TherapyJan M Sommerlath Sohns, Hannah Kröhn, Alexandra Schöde, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 24, 2025
Initial Experience with Dual-Time-Point [<sup>18</sup>F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary HyperparathyroidismThorsten Derlin, Dennis Kleine-Döpke, Lavinia Neubert, et al.Pageof 36